News
June 1-5, 2008
ASMS Conference on Mass Spectrometry, Denver
Please visit RECEPTORS' booth #26 at the ASMS Conference on Mass Spectrometry, June 1-5 in Denver, to learn about our Proteomics Toolkit for high-performance protein fractionation and purification.
Current
Our PROTEOME WINDOWS™ Fractionation Supports are now available for beta-testing in micro-spin and macro-spin formats. Please contact us to receive more information.
Spring, 2008
RECEPTORS expansion
RECEPTORS has increased staff by 50% and added administrative office space, enabling us to expand the scope of our research & development to meet the needs of our customers, partners, and collaborators.
December 4, 2007
Digital Angel Co., Verichip Co., and RECEPTORS LLC publish white paper for Self-Contained Implantable RFID Glucose-Sensing Microchip. Read Paper
Also featured on FoxNews.com - View Video
Affinity By Design (tm)
RECEPTORS' Proteomics Toolkit products are reliable and scalable tools for protein fractionation, biomarker discovery, and biopharmaceutical manufacturing. These products are being developed to address a fundamental roadblock confronting proteomics research and biopharmaceutical development: the efficient and economic separation of protein mixtures. The CARA® AFFINITY by DESIGN™ Discovery platform allows RECEPTORS to optimize artificial receptors to any application.
Our Products
WINDOWS into the PROTEOME™
Tools for High Performance Protein Fractionation
SPECIFICITY defined SIGNATURES™
Epitope Arrays for Rapid and Reproducible Biomolecule Fingerprinting
GOLDILOCKS "just right!" BIOPROCESSING™
High-Performance Supports for Antibody Processing
RECEPTORS' technology platform is directed to the creation and high-throughput selection of Artificial Binding Partners for virtually any target molecule. We call these artificial binders "Receptor Environments", hence our name.
RECEPTORS' Proteomics Toolkit consists of three distinct product families, all based on our CARA® platform technology. Together, these products provide molecular recognition-based solutions to applications ranging from biomarker discovery and bioprocessing to biosensor development.
RECEPTORS' AFFINITY by DESIGN™ Combinatorial Artificial Receptor Array (CARA®) technology was developed for the efficient creation of artificial binding partners to any target.
Proteomics research and biopharmaceutical development require efficient and economic protein separation. RECEPTORS' AFFINITY by DESIGN™ products are reliable and scalable tools for protein fractionation, biomarker discovery and biopharmaceutical manufacturing.